Abstract:Introduction “What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?” was identified as one of the James Lind Alliance Priority Setting Partnership’s top 10 research questions in cystic fibrosis (CF). Using electronic questionnaires, we aimed to gain a deeper understanding of this research priority. Method The work was led by the steering group representative of the UK CF community consisting of patients, carers and healthcare professionals (HCPs). Electronic questionnaires were completed over a 4-week period and promoted via online forums such as Twitter, the UK CF Trust and US CF Foundation websites and via professional networks. Analysis of the closed questions was completed using Microsoft Excel, with keyword analysis and the final thematic analysis completed using NVivo software. Results There were 313 respondents; 176/313 (56%) were from people with CF and their families. HCPs comprised of 10 professional groups accounting for 137/313 (44%) of respondents, with global involvement of participants with the majority from the UK. Common themes identified as impacting on adherence included: having no time, treatment burden, competing life demands, fatigue and the patient’s general health. Having a routine was identified as the most frequently used motivational strategy, valued by both the patient and professional community. However, some strategies were valued more by HCPs than used in practice by patients; these included the use of short-term goal setting and technology use. Conclusion Adherence to treatment is crucial, however it is often suboptimal and strategies valued by HCPs to promote adherence are not always shared by patients. To promote adherence clinicians and researchers should be mindful that in a condition where treatment burden and time pressures are considerable, any interventions should focus on simplifying care and reducing treatment burden.

Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes

New drugs, new challenges in cystic fibrosis care

Improving gastrointestinal health in children and young people with cystic fibrosis

Exploring the complexity of cystic fibrosis (CF) and psychosocial wellbeing in the 2020s: Current and future challenges

The ageing of Cystic Fibrosis patients with new modulators: current gaps and challenges

Prognosis-Based Early Intervention Strategies to Resolve Exacerbation and Progressive Lung Function Decline in Cystic Fibrosis

Hope in Every Breath: Navigating the Therapeutic Landscape of Cystic Fibrosis

[Therapeutics in cystic fibrosis: Clinical revolution and new challenges]

The ageing of people living with cystic fibrosis: what to expect now?

Advances in Care and Outcomes for Children with Cystic Fibrosis

Outpatient management of pulmonary exacerbations in children with cystic fibrosis

Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy

Advances in the restoration of CFTR in children and pwCF with "mild disease"

Future therapies for cystic fibrosis

Update on advances in cystic fibrosis towards a cure and implications for primary care clinicians

What the future holds: cystic fibrosis and aging

The future of cystic fibrosis: A global perspective

Standards for the care of people with cystic fibrosis; establishing and maintaining health

Pulmonary Complications in Cystic Fibrosis: Past, Present, and Future: Adult Cystic Fibrosis Series

Implications for the Microbial Landscape in Cystic Fibrosis

What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?